PreludeDx
PrivateLast Round
VC Round
Mar 22, 2022
Total Funding Raised
$3.51M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PreludeDx is a biotechnology company that develops and provides precision diagnostic tests for early-stage breast cancer.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PreludeDx Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
PreludeDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 22, 2022 | ||||
| Strategic | Jul 19, 2021 | ||||
| Grant | Jan 1, 2014 | ||||
| Series A | Jul 27, 2011 |
Key People
Founding team and executive leadership
PreludeDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Fjord Ventures | VC Round, Series A |
| Evidity Health Capital | VC Round |
| BlueStone Venture Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Received designation for AidaBreast test for early-stage invasive breast cancer.
- Jan 22, 2026
MiMi Reyes appointed as new SVP of Operations.
PreludeDx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PreludeDx's valuation, stock price, and market status.